FKBP5 rs1360787: Genetic Variation and Stress Sensitivity

What each genotype means

What Is rs1360787 and Where Is It Located?

The single-nucleotide polymorphism rs1360787 is a non-coding variant situated within the human FKBP5 gene on chromosome 6p21.31. Variants across this genomic locus typically occur in regulatory regions, such as introns, where they can influence transcriptional efficiency, chromatin architecture, or responsiveness to cellular signals rather than directly altering the amino acid sequence of the protein. The FKBP5 locus contains several single-nucleotide polymorphisms that are frequently inherited together in distinct haplotypes across human populations. Because rs1360787 is located in a regulatory section of the gene, researchers have focused on how its presence might modify transcription factor binding and the overall induction of the gene's messenger RNA in response to physiological stress. In genomic reference catalogs such as dbSNP, rs1360787 represents a common biallelic variation. While not a direct coding mutation that disrupts protein structure, changes in these non-coding regulatory sequences can modulate how dynamically the surrounding gene responds to fluctuating physiological conditions.

Biological Role of FKBP5 in Stress Physiology

The FKBP5 gene encodes the FK506-binding protein 51 (FKBP51), an immunophilin co-chaperone that plays a pivotal role in the human stress response. FKBP51 interacts directly with heat shock protein 90 (Hsp90) and the glucocorticoid receptor (GR) in the cytoplasm. When FKBP51 is bound within this chaperone heterocomplex, the receptor exhibits lower binding affinity for cortisol and other glucocorticoids, effectively delaying its nuclear translocation and transcriptional activity. Once glucocorticoids activate the pathway, FKBP5 transcription is naturally induced as part of an ultra-short intracellular negative feedback loop, which acts to attenuate excessive glucocorticoid signaling. Proper calibration of this feedback loop is necessary for the normal functioning of the hypothalamic-pituitary-adrenal (HPA) axis. When regulatory variations perturb the baseline or induced levels of FKBP51 expression, the sensitivity of the glucocorticoid receptor shifts. This can reduce the efficiency of negative feedback, prolong circulating cortisol elevation, and alter how neural circuits adapt to environmental stressors.

Scientific Evidence and Neuropsychiatric Associations

Published candidate-gene studies and neuropsychiatric research have investigated variations across the FKBP5 locus—including rs1360787 and closely linked variants—for associations with conditions such as major depressive disorder, post-traumatic stress disorder (PTSD), and altered stress reactivity. According to curated catalogs, the overall evidence strength for rs1360787 as an independent diagnostic predictor remains limited. Many genetic studies in this field highlight a gene-environment interaction (GxE) framework: specific alleles often do not confer elevated risk on their own, but rather demonstrate altered vulnerability or resilience in individuals exposed to significant early-life adversity or chronic trauma. Furthermore, findings across large genome-wide association studies (GWAS) have yielded mixed or modest effect sizes when examining unstratified populations, underscoring that FKBP5 variation does not act deterministically. Instead, it serves as one subtle component in a polygenic and highly environmentally mediated network governing psychological and neuroendocrine stress responses.

Understanding Ancestry and Population Frequencies

Allele frequencies for FKBP5 polymorphisms show notable variation across ancestral backgrounds. For rs1360787, genomic databases and catalog records indicate a minor allele frequency of approximately 0.30 in populations of European ancestry. In contrast, the minor allele frequency is noticeably lower in East Asian populations, observed at approximately 0.10. These differences in baseline allele frequencies mean that the distribution of homozygous and heterozygous genotypes differs widely between global populations. Understanding these frequency differences is essential in genetic research, as associations observed in one ancestral group cannot be assumed to generalize directly to another without replication. Differences in linkage disequilibrium—the degree to which adjacent genetic markers are co-inherited—also vary by ancestry, meaning that rs1360787 may track alongside different regulatory variants depending on an individual's genetic background.

What You Can and Cannot Do with This Result

Learning your rs1360787 genotype does not provide a medical diagnosis, nor does it predict whether you will develop any stress-related condition. The evidence linking this variant to clinical outcomes is classified as limited, and genetic factors account for only a small portion of overall mental health. A genotype associated with higher stress sensitivity is neither a guarantee of illness nor a sign of dysfunction; conversely, carrying baseline alleles does not confer immunity to stress or psychological disorders. Consumers should never use personal genomic information to alter medical treatments, discontinue therapies, or adjust the dosage of any prescribed medication. If you have questions about how your genetics may interact with your health or medication regimen, consult a qualified healthcare professional, genetic counselor, or clinical pharmacist for individualized guidance.

Frequently asked questions

Sources & further reading